Skip to main content

and
  1. Article

    Open Access

    Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report

    Increasingly widespread use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors (ICIs) for treatment of a variety of progressive malignancies continues to reveal a range of immune-related ad...

    Jacobi Hines, Ellen Daily, Anh Khoa Pham in Journal of Medical Case Reports (2021)